Monday, August 27, 2018 4:45:19 PM
When Emily was diagnosed with aggressive brain cancer earlier this year, Laura was devastated.
“I sobbed. I sat in the middle of the exam room and sobbed,” recalled Laura Kamienski.
emily the dog Experimental Cancer Drug For Dogs Could Hold Promise For People
(CBS4)
Emily has Glioblastoma and was given just three months to live. It’s a tough cancer to treat and options are limited. So Laura enrolled Emily in a new clinical trial at the Virginia-Maryland College of Veterinary Medicine at Virginia Tech.
“That gave me hope,” she said, “I said ‘I’ll do anything’.”
A drug is injected directly into the tumor, getting right to the cancer while leaving healthy brain tissue undamaged.
“We watch the entire treatment on MRI. So we can watch the drug cover the tumor. And so we know we’ve achieved the treatment goals of actually targeting all the cancer cells,” explained Dr. John Rossmeisl, Professor Neurology and Neurosurgery.
Researchers say results are so promising the National Institutes of Health is now helping fund the trial hoping it can lead to a breakthrough for people.
In the meantime, it has been six weeks since Emily’s first treatment.
“She hasn’t had a seizure since last time. She’s herself,” said Kamienski.
MRI’s show her tumor is shrinking.
“The black spot means the tumor that actually means the tumor is dying. That’s what we want to see,” explained Dr. Rossmeisl. “The only way this could have been better if it was totally gone. This is really good news.”
“It’s not a cure, I knew that going in,” said Kamienski. “This is the best hope, to give her more time.”
And maybe someday, saving people trying to beat this cancer.
In partnership with Wake Forest University, Virginia Maryland Veterinary College is still accepting dogs with glioblastoma into the clinical trial.
Recent RDGL News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/04/2024 06:28:50 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 09:30:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/27/2023 09:40:48 PM
- Form QUALIF - Notice of Qualification [Regulation A] • Edgar (US Regulatory) • 12/07/2023 05:15:10 AM
- Form 1-A POS - • Edgar (US Regulatory) • 11/27/2023 10:29:12 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/06/2023 04:28:46 PM
- Form 1-A POS - • Edgar (US Regulatory) • 11/03/2023 09:03:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/19/2023 04:18:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/11/2023 10:33:58 AM
- Form 1-A POS - • Edgar (US Regulatory) • 10/10/2023 04:05:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/04/2023 07:22:21 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM